Evidence map›Paper›PMID 40388957›Full record

ReviewThe Lancet. Haematology2025

Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.

Omran Saifi, Chelsea C Pinnix, Chris R Kelsey, Leslie K Ballas, Sarah A Milgrom, Ranjana Advani, Margaret T Kasner, Stella Flampouri, Stephanie A Terezakis, Mark Sellmyer and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Lancet. Haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Omran SaifiDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.
Chelsea C PinnixDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chris R KelseyDepartment of Radiation Oncology, Duke Cancer Institute, Durham, NC, USA.
Leslie K BallasDepartment of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Sarah A MilgromDepartment of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
Ranjana AdvaniDivision of Hematology and Oncology, Stanford Cancer Institute, Stanford, CA, USA.
Margaret T KasnerDivision of Hematology and Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Stella FlampouriDepartment of Radiation Oncology, Emory University, Atlanta, GA, USA.
Stephanie A TerezakisDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, USA.
Mark SellmyerDepartment of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
John P PlastarasDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Bradford S HoppeDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. Electronic address: hoppe.bradford@mayo.edu.

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
NCI NIH HHS U10 CA180868
6 · The paper itself

Abstract

There has been a notable decrease in the use of radiation in lymphoma clinical practice and research in recent years. The NRG Hematologic Malignancies Working Group aimed to assess the inclusion of radiation oncology alongside haematology and oncology, pathology and molecular biology, and diagnostic radiology and nuclear medicine in lymphoma academic leadership positions. The haematology and oncology specialty had the highest representation among National Comprehensive Cancer Network lymphoma guideline committees, lymphoma research cooperative groups, lymphoma research foundations, and the editorial boards of seven high-impact haematology journals, with under-representation of radiation oncology and other specialties, such as diagnostic radiology and nuclear medicine. The NRG Hematologic Malignancies Working Group advocates for increased multidisciplinary representation and collaboration to enhance the quality of care and improve outcomes for patients with lymphoma.

Indexed as

LymphomaRadiation OncologyHumans

Identifiers

PMID40388957
PMCPMC12947659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.